Rao constructed hybrid vesicles based on tumor cell membrane vesicles, M1 macrophage-derived vesicles and platelet derived vesicles, and modified SIRPα protein on the hybrid vesicles through genetic engineering to block the immune escape pathway of tumor cells (Figure 3A) (Rao et al., 2020). This evidence concerns the gene SIRPA and neoplasm.